Pre-existing Fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation.
about
Pre-existing Fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pre-existing Fas ligand (FasL) ...... n facilitates tumor formation.
@en
Pre-existing Fas ligand (FasL) ...... n facilitates tumor formation.
@nl
type
label
Pre-existing Fas ligand (FasL) ...... n facilitates tumor formation.
@en
Pre-existing Fas ligand (FasL) ...... n facilitates tumor formation.
@nl
prefLabel
Pre-existing Fas ligand (FasL) ...... n facilitates tumor formation.
@en
Pre-existing Fas ligand (FasL) ...... n facilitates tumor formation.
@nl
P2093
P2860
P356
P1476
Pre-existing Fas ligand (FasL) ...... n facilitates tumor formation.
@en
P2093
Chia-Yi Chu
Guang-Huan Sun
Hsiao-Hsien Wang
Hsiao-Ying Chiu
Kuang-Hui Sun
Ming-Yi Ho
Ren-Shiang Jhou
Rui-Ting Huang
Shiow-Yi Chen
Shye-Jye Tang
P2860
P304
P356
10.1002/MC.21909
P577
2012-04-09T00:00:00Z